Shares of Abbott Laboratories (ABT) rose ahead of the market open on Wednesday, Jan. 24, after the healthcare firm reported fourth-quarter results that exceeded analysts' estimates.

Shares were trading at $60.70, up 2.5%.

With Abbott's stock up more than 50% in 2017, "investors were mixed heading into 4Q earnings and 2018 guidance event," Evercore ISI analyst Vijay Kumar wrote in a note. "ABT did not disappoint, and the 4Q print was impressive across the board."

Abbott reported adjusted diluted earnings per share from continuing operations of 74 cents on revenue of $7.6 billion. Analysts had forecast adjusted EPS of 73 cents on revenue of $7.38 billion, according to Bloomberg.

For 2018, the Abbott Park, Ill., company projected adjusted EPS from continuing operations of $2.80 to $2.90.

Abbott is a holding in Jim Cramer's Action Alerts PLUS Charitable Trust Portfolio. Want to be alerted before Cramer and the AAP team buy or sell ABT? Learn more now.

More of What's Trending on TheStreet:

 

More from Stocks

Why Auto Parts Stocks Are Getting Hammered

Why Auto Parts Stocks Are Getting Hammered

A Guide to Investing in the Fast-Emerging Cannabis Industry

A Guide to Investing in the Fast-Emerging Cannabis Industry

Tesla Buys Land in China to Begin Gigafactory Construction

Tesla Buys Land in China to Begin Gigafactory Construction

Improved Charts and Breadth Suggest More Upside for Stocks

Improved Charts and Breadth Suggest More Upside for Stocks

Dow Wavers as Gains in Goldman Sachs Offset IBM's Slump

Dow Wavers as Gains in Goldman Sachs Offset IBM's Slump